{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:43:01Z","timestamp":1791430981551,"version":"4.3.3"},"reference-count":87,"publisher":"Bentham Science Publishers Ltd.","issue":"4","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81603024"],"award-info":[{"award-number":["81603024"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CCHTS"],"published-print":{"date-parts":[[2020,5,19]]},"abstract":"<jats:sec>\n<jats:title>Aim and Objective:<\/jats:title>\n<jats:p> Leukemia is the second common blood cancer after lymphoma, and\nits incidence rate has an increasing trend in recent years. Leukemia can be classified into four types:\nacute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic\nleukemia (CLL), and chronic myelogenous leukemia (CML). More than forty drugs are applicable to\ndifferent types of leukemia based on the discrepant pathogenesis. Therefore, the identification of\nspecific drug-targeted biological processes and pathways is helpful to determinate the underlying\npathogenesis among such four types of leukemia.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>In this study, the gene ontology (GO) terms and Kyoto Encyclopedia of Genes and\nGenomes (KEGG) pathways that were highly related to drugs for leukemia were investigated for the\nfirst time. The enrichment scores for associated GO terms and KEGG pathways were calculated to\nevaluate the drugs and leukemia. The feature selection method, minimum redundancy maximum\nrelevance (mRMR), was used to analyze and identify important GO terms and KEGG pathways.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Twenty Go terms and two KEGG pathways with high scores have all been confirmed to\neffectively distinguish four types of leukemia.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>This analysis may provide a useful tool for the discrepant pathogenesis and drug design\nof different types of leukemia.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1386207322666181231151900","type":"journal-article","created":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T13:47:51Z","timestamp":1546350471000},"page":"295-303","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Analysis of Four Types of Leukemia Using Gene Ontology Term and Kyoto Encyclopedia of Genes and Genomes Pathway Enrichment Scores"],"prefix":"10.2174","volume":"23","author":[{"given":"Jing","family":"Lu","sequence":"first","affiliation":[{"name":"School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, 32 Qingquan Road, Yantai 264005, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YuHang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yueyang Road, Shanghai 200031, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ShaoPeng","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Life Sciences, Shanghai University, 99 Shangda Road, Shanghai 200444, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Bi","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, 32 Qingquan Road, Yantai 264005, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Huang","sequence":"additional","affiliation":[{"name":"Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yueyang Road, Shanghai 200031, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Luo","sequence":"additional","affiliation":[{"name":"Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of MateriaMedica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Dong","family":"Cai","sequence":"additional","affiliation":[{"name":"School of Life Sciences, Shanghai University, 99 Shangda Road, Shanghai 200444, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","unstructured":"A Snapshot of Leukemia.  [Accessed on October 2017]."},{"key":"ref=2","first-page":"1145","volume":"56","author":"Cri\u015fan A.M.","year":"2015","unstructured":"Cri\u015fan A.M.; B\u0103deli\u0162\u0103 S.N.; Jardan C.; Vasilache E.D.; Dobrea C.M.; Gheorghe A.; T\u0103lmaci R.; Arion C.V.; Barda\u015f A.; G\u0103man A.M.; Coriu D.; The occurrence of chronic lymphocytic leukemia after chronic phase of chronic myeloid leukemia: case report and literature review. Rom J Morphol Embryol 2015,56(3),1145-1151","journal-title":"Rom J Morphol Embryol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.2169\/internalmedicine.52.0392","volume":"52","author":"Nagao T.","year":"2013","unstructured":"Nagao T.; Takahashi N.; Kameoka Y.; Noguchi S.; Shinohara Y.; Ohyagi H.; Kume M.; Sawada K.; Dasatinib-responsive chronic lymphocytic leukemia in a patient treated for coexisting chronic myeloid leukemia. Intern Med 2013,52(22),2567-2571","journal-title":"Intern Med"},{"key":"ref=4","first-page":"67","volume":"10","author":"Mosavi-Jarrahi A.","year":"2009","unstructured":"Mosavi-Jarrahi A.; Mohagheghi M.A.; Kalaghchi B.; Mousavi-Jarrahi Y.; Kolahi A.A.; Noori M.K.; Estimating the incidence of leukemia attributable to occupational exposure in Iran. Asian Pac J Cancer Prev 2009,10(1),67-70","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s00277-009-0731-9","volume":"88","author":"Kaufman D.W.","year":"2009","unstructured":"Kaufman D.W.; Anderson T.E.; Issaragrisil S.; Risk factors for leukemia in Thailand. Ann Hematol 2009,88(11),1079-1088","journal-title":"Ann Hematol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.3346\/jkms.2010.25.S.S99","volume":"25","author":"Kim E.A.","year":"2010","unstructured":"Kim E.A.; Lee W.J.; Son M.; Kang S.K.; Occupational lymphohematopoietic cancer in Korea. J Korean Med Sci 2010,25(Suppl.),S99-S104","journal-title":"J Korean Med Sci"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1182\/blood-2011-03-341412","volume":"118","author":"Zhang J.","year":"2011","unstructured":"Zhang J.; Mullighan C.G.; Harvey R.C.; Wu G.; Chen X.; Edmonson M.; Buetow K.H.; Carroll W.L.; Chen I.M.; Devidas M.; Gerhard D.S.; Loh M.L.; Reaman G.H.; Relling M.V.; Camitta B.M.; Bowman W.P.; Smith M.A.; Willman C.L.; Downing J.R.; Hunger S.P.; Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children\u2019s Oncology Group. Blood 2011,118(11),3080-3087","journal-title":"Blood"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1182\/blood-2005-05-1898","volume":"106","author":"Levine R.L.","year":"2005","unstructured":"Levine R.L.; Loriaux M.; Huntly B.J.; Loh M.L.; Beran M.; Stoffregen E.; Berger R.; Clark J.J.; Willis S.G.; Nguyen K.T.; Flores N.J.; Estey E.; Gattermann N.; Armstrong S.; Look A.T.; Griffin J.D.; Bernard O.A.; Heinrich M.C.; Gilliland D.G.; Druker B.; Deininger M.W.; The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia. Blood 2005,106(10),3377-3379","journal-title":"Blood"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1073\/pnas.0308648100","volume":"101","author":"Lu D.","year":"2004","unstructured":"Lu D.; Zhao Y.; Tawatao R.; Cottam H.B.; Sen M.; Leoni L.M.; Kipps T.J.; Corr M.; Carson D.A.; Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2004,101(9),3118-3123","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1126\/science.1186624","volume":"327","author":"Wang Y.","year":"2010","unstructured":"Wang Y.; Krivtsov A.V.; Sinha A.U.; North T.E.; Goessling W.; Feng Z.; Zon L.I.; Armstrong S.A.; The Wnt\/\u03b2-catenin pathway is required for the development of leukemia stem cells in AML. Science 2010,327(5973),1650-1653","journal-title":"Science"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1182\/blood-2006-09-047043","volume":"109","author":"Rom\u00e1n-G\u00f3mez J.","year":"2007","unstructured":"Rom\u00e1n-G\u00f3mez J.; Cordeu L.; Agirre X.; Jim\u00e9nez-Velasco A.; San Jos\u00e9-Eneriz E.; Garate L.; Calasanz M.J.; Heiniger A.; Torres A.; Prosper F.; Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia. Blood 2007,109(8),3462-3469","journal-title":"Blood"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/sj.leu.2404657","volume":"21","author":"Sengupta A.","year":"2007","unstructured":"Sengupta A.; Banerjee D.; Chandra S.; Banerji S.K.; Ghosh R.; Roy R.; Banerjee S.; Deregulation and cross talk among Sonic hedgehog, Wnt, Hox and Notch signaling in chronic myeloid leukemia progression. Leukemia 2007,21(5),949-955","journal-title":"Leukemia"},{"key":"ref=13","unstructured":"Drugs Approved for Leukemia[Accessed on October 2017]."},{"key":"ref=14","unstructured":"Imatinib Mesylate [Accessed on October 2017]."},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1038\/sj.leu.2403775","volume":"19","author":"Gambacorti-Passerini C.","year":"2005","unstructured":"Gambacorti-Passerini C.; Gasser M.; Ahmed S.; Assouline S.; Scapozza L.; Abl inhibitor BMS354825 binding mode in Abelson kinase revealed by molecular docking studies. Leukemia 2005,19(7),1267-1269","journal-title":"Leukemia"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1021\/acs.jcim.6b00185","volume":"56","author":"Xu Y.","year":"2016","unstructured":"Xu Y.; Yue L.; Wang Y.; Xing J.; Chen Z.; Shi Z.; Liu R.; Liu Y.C.; Luo X.; Jiang H.; Chen K.; Luo C.; Zheng M.; Discovery of novel inhibitors targeting the menin-mixed lineage leukemia interface using pharmacophore- and docking-based virtual screening. J Chem Inf Model 2016,56(9),1847-1855","journal-title":"J Chem Inf Model"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1021\/jm060849b","volume":"50","author":"P\u00e9rez-Sacau E.","year":"2007","unstructured":"P\u00e9rez-Sacau E.; D\u00edaz-Pe\u00f1ate R.G.; Est\u00e9vez-Braun A.; Ravelo A.G.; Garc\u00eda-Castellano J.M.; Pardo L.; Campillo M.; Synthesis and pharmacophore modeling of naphthoquinone derivatives with cytotoxic activity in human promyelocytic leukemia HL-60 cell line. J Med Chem 2007,50(4),696-706","journal-title":"J Med Chem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00894-011-1057-9","volume":"18","author":"Naik P.K.","year":"2012","unstructured":"Naik P.K.; Santoshi S.; Joshi H.C.; Noscapinoids with anti-cancer activity against human acute lymphoblastic leukemia cells (CEM): a three dimensional chemical space pharmacophore modeling and electronic feature analysis. J Mol Model 2012,18(1),307-318","journal-title":"J Mol Model"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"Kanehisa M.","year":"2016","unstructured":"Kanehisa M.; Sato Y.; Kawashima M.; Furumichi M.; Tanabe M.; KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res 2016,44(Database issue),D457-D462","journal-title":"Nucleic Acids Res"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1016\/j.bbagen.2016.01.012","volume":"1860","author":"Xing Z.","year":"2016","unstructured":"Xing Z.; Chu C.; Chen L.; Kong X.; The use of Gene Ontology terms and KEGG pathways for analysis and prediction of oncogenes. Biochim Biophys Acta 2016,1860(11, Part B),2725-2734","journal-title":"Biochim Biophys Acta"},{"key":"ref=21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126492","volume":"10","author":"Chen L.","year":"2015","unstructured":"Chen L.; Chu C.; Lu J.; Kong X.; Huang T.; Cai Y.D.; Gene ontology and KEGG pathway enrichment analysis of a drug target-based classification system. PLoS One 2015,10(5)","journal-title":"PLoS One"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1109\/TPAMI.2005.159","volume":"27","author":"Peng H.","year":"2005","unstructured":"Peng H.; Long F.; Ding C.; Feature selection based on mutual information: criteria of max-dependency, max-relevance, and min-redundancy. IEEE Trans Pattern Anal Mach Intell 2005,27(8),1226-1238","journal-title":"IEEE Trans Pattern Anal Mach Intell"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"D1049","DOI":"10.1093\/nar\/gku1179","volume":"43","author":"Blake J.A.","year":"2015","unstructured":"Blake J.A.; Christie K.R.; Dolan M.E.; Drabkin H.J.; Hill D.P.; Ni L.; Sitnikov D.; Burgess S.; Buza T.; Gresham C.; McCarthy F.; Pillai L.; Wang H.; Carbon S.; Dietze H.; Lewis S.E.; Mungall C.J.; Munoz-Torres M.C.; Feuermann M.; Gaudet P.; Basu S.; Chisholm R.L.; Dodson R.J.; Fey P.; Mi H.; Thomas P.D.; Muruganujan A.; Poudel S.; Hu J.C.; Aleksander S.A.; McIntosh B.K.; Renfro D.P.; Siegele D.A.; Attrill H.; Brown N.H.; Tweedie S.; Lomax J.; Osumi-Sutherland D.; Parkinson H.; Roncaglia P.; Lovering R.C.; Talmud P.J.; Humphries S.E.; Denny P.; Campbell N.H.; Foulger R.E.; Chibucos M.C.; Gwinn Giglio M.; Chang H.Y.; Finn R.; Fraser M.; Mitchell A.; Nuka G.; Pesseat S.; Sangrador A.; Scheremetjew M.; Young S.Y.; Stephan R.; Harris M.A.; Oliver S.G.; Rutherford K.; Wood V.; Bahler J.; Lock A.; Kersey P.J.; McDowall M.D.; Staines D.M.; Dwinell M.; Shimoyama M.; Laulederkind S.; Hayman G.T.; Wang S.J.; Petri V.; D\u2019Eustachio P.; Matthews L.; Balakrishnan R.; Binkley G.; Cherry J.M.; Costanzo M.C.; Demeter J.; Dwight S.S.; Engel S.R.; Hitz B.C.; Inglis D.O.; Lloyd P.; Miyasato S.R.; Paskov K.; Roe G.; Simison M.; Nash R.S.; Skrzypek M.S.; Weng S.; Wong E.D.; Berardini T.Z.; Li D.; Huala E.; Argasinska J.; Arighi C.; Auchincloss A.; Axelsen K.; Argoud-Puy G.; Bateman A.; Bely B.; Blatter M.C.; Bonilla C.; Bougueleret L.; Boutet E.; Breuza L.; Bridge A.; Britto R.; Casals C.; Cibrian-Uhalte E.; Coudert E.; Cusin I.; Duek-Roggli P.; Estreicher A.; Famiglietti L.; Gane P.; Garmiri P.; Gos A.; Gruaz-Gumowski N.; Hatton-Ellis E.; Hinz U.; Hulo C.; Huntley R.; Jungo F.; Keller G.; Laiho K.; Lemercier P.; Lieberherr D.; MacDougall A.; Magrane M.; Martin M.; Masson P.; Mutowo P.; O\u2019Donovan C.; Pedruzzi I.; Pichler K.; Poggioli D.; Poux S.; Rivoire C.; Roechert B.; Sawford T.; Schneider M.; Shypitsyna A.; Stutz A.; Sundaram S.; Tognolli M.; Wu C.; Xenarios I.; Chan J.; Kishore R.; Sternberg P.W.; Van Auken K.; Muller H.M.; Done J.; Li Y.; Howe D.; Westerfield M.; Gene Ontology Consortium: going forward. Nucleic Acids Res 2015,43(Database issue),D1049-D1056","journal-title":"Nucleic Acids Res"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"Kanehisa M.","year":"2000","unstructured":"Kanehisa M.; Goto S.; KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000,28(1),27-30","journal-title":"Nucleic Acids Res"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"D684","DOI":"10.1093\/nar\/gkm795","volume":"36","author":"Kuhn M.","year":"2008","unstructured":"Kuhn M.; von Mering C.; Campillos M.; Jensen L.J.; Bork P.; STITCH: interaction networks of chemicals and proteins. Nucleic Acids Res 2008,36(Database issue),D684-D688","journal-title":"Nucleic Acids Res"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"D552","DOI":"10.1093\/nar\/gkp937","volume":"38","author":"Kuhn M.","year":"2010","unstructured":"Kuhn M.; Szklarczyk D.; Franceschini A.; Campillos M.; von Mering C.; Jensen L.J.; Beyer A.; Bork P.; STITCH 2: an interaction network database for small molecules and proteins. Nucleic Acids Res 2010,38(Database issue),D552-D556","journal-title":"Nucleic Acids Res"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"R3","DOI":"10.1186\/gb-2007-8-1-r3","volume":"8","author":"Carmona-Saez P.","year":"2007","unstructured":"Carmona-Saez P.; Chagoyen M.; Tirado F.; Carazo J.M.; Pascual-Montano A.; GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists. Genome Biol 2007,8(1),R3","journal-title":"Genome Biol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.biochi.2011.12.024","volume":"94","author":"Papadopoulos P.","year":"2012","unstructured":"Papadopoulos P.; Tianfield H.; Moffat D.; Barrie P.; Deciphering the effects of gene deletion on yeast longevity using network and machine learning approaches. Biochimie 2012,94(4),1017-1025","journal-title":"Biochimie"},{"key":"ref=29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0165496","volume":"11","author":"Zhang Y.H.","year":"2016","unstructured":"Zhang Y.H.; Chu C.; Wang S.; Chen L.; Lu J.; Kong X.; Huang T.; Li H.; Cai Y.D.; The use of gene ontology term and KEGG pathway enrichment for analysis of drug half-life. PLoS One 2016,11(10)","journal-title":"PLoS One"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1016\/j.bbagen.2016.05.015","volume":"1860","author":"Chen L.","year":"2016","unstructured":"Chen L.; Zhang Y.H.; Zou Q.; Chu C.; Ji Z.; Analysis of the chemical toxicity effects using the enrichment of Gene Ontology terms and KEGG pathways. Biochim Biophys Acta 2016,1860(11, Part B),2619-2626","journal-title":"Biochim Biophys Acta"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/1471-2105-11-325","volume":"11","author":"Li Z.","year":"2010","unstructured":"Li Z.; Zhou X.; Dai Z.; Zou X.; Classification of G-protein coupled receptors based on support vector machine with maximum relevance minimum redundancy and genetic algorithm. BMC Bioinformatics 2010,11,325","journal-title":"BMC Bioinformatics"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"23075","DOI":"10.1038\/srep23075","volume":"6","author":"Chen L.","year":"2016","unstructured":"Chen L.; Zhang Y.H.; Huang T.; Cai Y.D.; Gene expression profiling gut microbiota in different races of humans. Sci Rep 2016,6,23075","journal-title":"Sci Rep"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1186\/s12864-015-2328-0","volume":"16","author":"Huang T.","year":"2015","unstructured":"Huang T.; Shu Y.; Cai Y.D.; Genetic differences among ethnic groups. BMC Genomics 2015,16,1093","journal-title":"BMC Genomics"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1017\/S1355617704102075","volume":"10","author":"Schatz J.","year":"2004","unstructured":"Schatz J.; Kramer J.H.; Ablin A.R.; Matthay K.K.; Visual attention in long-term survivors of leukemia receiving cranial radiation therapy. J Int Neuropsychol Soc 2004,10(2),211-220","journal-title":"J Int Neuropsychol Soc"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/eye.2001.220","volume":"15","author":"Ismail A.","year":"2001","unstructured":"Ismail A.; Verity D.; Brittain P.; Visual loss as the presenting feature of acute myeloid leukaemia. Eye 2001,15(5),681-682","journal-title":"Eye"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1055\/s-2007-973786","volume":"27","author":"Uberall M.A.","year":"1996","unstructured":"Uberall M.A.; Hertzberg H.; Meier W.; Langer T.; Beck J.D.; Wenzel D.; Visual-evoked potentials in long-term survivors of acute lymphoblastic leukemia in childhood. The German Late Effects Working Group. Neuropediatrics 1996,27(4),194-196","journal-title":"Neuropediatrics"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1182\/blood-2013-07-515361","volume":"123","author":"Woyach J.A.","year":"2014","unstructured":"Woyach J.A.; Bojnik E.; Ruppert A.S.; Stefanovski M.R.; Goettl V.M.; Smucker K.A.; Smith L.L.; Dubovsky J.A.; Towns W.H.; MacMurray J.; Harrington B.K.; Davis M.E.; Gobessi S.; Laurenti L.; Chang B.Y.; Buggy J.J.; Efremov D.G.; Byrd J.C.; Johnson A.J.; Bruton\u2019s tyrosine kinase (BTK) function is important to the development and expansion of chronic lymphocytic leukemia (CLL). Blood 2014,123(8),1207-1213","journal-title":"Blood"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/bjh.12867","volume":"166","author":"Sivina M.","year":"2014","unstructured":"Sivina M.; Kreitman R.J.; Arons E.; Ravandi F.; Burger J.A.; The bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) blocks hairy cell leukaemia survival, proliferation and B cell receptor signalling: a new therapeutic approach. Br J Haematol 2014,166(2),177-188","journal-title":"Br J Haematol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1182\/blood-2014-06-585216","volume":"125","author":"Oellerich T.","year":"2015","unstructured":"Oellerich T.; Mohr S.; Corso J.; Beck J.; D\u00f6bele C.; Braun H.; Cremer A.; M\u00fcnch S.; Wicht J.; Oellerich M.F.; Bug G.; Bohnenberger H.; Perske C.; Sch\u00fctz E.; Urlaub H.; Serve H.; FLT3-ITD and TLR9 use Bruton tyrosine kinase to activate distinct transcriptional programs mediating AML cell survival and proliferation. Blood 2015,125(12),1936-1947","journal-title":"Blood"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1038\/sj.leu.2404009","volume":"19","author":"Christiansen D.H.","year":"2005","unstructured":"Christiansen D.H.; Andersen M.K.; Desta F.; Pedersen-Bjergaard J.; Mutations of genes in the receptor tyrosine kinase (RTK)\/RAS-BRAF signal transduction pathway in therapy-related myelodysplasia and acute myeloid leukemia. Leukemia 2005,19(12),2232-2240","journal-title":"Leukemia"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1053\/j.seminoncol.2016.02.008","volume":"43","author":"Maddocks K.","year":"2016","unstructured":"Maddocks K.; Jones J.A.; Bruton tyrosine kinase inhibition in chronic lymphocytic leukemia. Semin Oncol 2016,43(2),251-259","journal-title":"Semin Oncol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1158\/1078-0432.CCR-14-1892","volume":"124","author":"Sinha S.","year":"2014","unstructured":"Sinha S.; Boysen J.; Nelson M.; Secreto C.; Warner S.L.; Bearss D.J.; Lesnick C.; Shanafelt T.D.; Kay N.E.; Ghosh A.K.; Targeted inhibition of Axl primes chronic lymphocytic leukemia B-cells for apoptosis: Synergistic\/additive effects in combination with bruton tyrosine kinase inhibitors. Blood 2014,124(21),1946","journal-title":"Blood"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1182\/blood-2013-07-515361","volume":"120","author":"Woyach J.A.","year":"2012","unstructured":"Woyach J.A.; Stefanovski M.R.; Goettl V.; Ruppert A.S.; Smucker K.A.; Smith L.L.; Dubovsky J.A.; Towns W.H.; MacMurray J.; Davis M.E.; Mao Y.; Chang B.Y.; Buggy J.J.; Byrd J.C.; Johnson A.J.; Global inhibition of bruton\u2019s tyrosine kinase (BTK) delays the development and expansion of chronic lymphocytic leukemia (CLL) in the TCL1 mouse model of disease. Blood 2012,120(21),183-183","journal-title":"Blood"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"9414","DOI":"10.1073\/pnas.0811761106","volume":"106","author":"Mullighan C.G.","year":"2009","unstructured":"Mullighan C.G.; Zhang J.; Harvey R.C.; Collins-Underwood J.R.; Schulman B.A.; Phillips L.A.; Tasian S.K.; Loh M.L.; Su X.; Liu W.; Devidas M.; Atlas S.R.; Chen I.M.; Clifford R.J.; Gerhard D.S.; Carroll W.L.; Reaman G.H.; Smith M.; Downing J.R.; Hunger S.P.; Willman C.L.; JAK mutations in high-risk childhood acute lymphoblastic leukemia. Proc Natl Acad Sci USA 2009,106(23),9414-9418","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1182\/blood.V116.21.2752.2752","volume":"116","author":"Zhang J.","year":"2010","unstructured":"Zhang J.; Mullighan C.; Harvey R.; Carroll W.L.; Chen I.M.L.; Devidas M.; Larsen E.; Edmonson M.; Buetow K.; Gerhard D.S.; Loh M.L.; Reaman G.H.; Relling M.V.; Smith M.A.; Downing J.R.; Willman C.L.; Hunger S.; Lack of somatic sequence mutations in protein tyrosine kinase genes other than the jak kinase family in high risk b-precursor childhood acute lymphoblastic leukemia (ALL): A Report From the Children\u2019s Oncology Group (COG) High-Risk (HR) ALL TARGET Project. Blood 2010,116(21),2752-2752","journal-title":"Blood"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1158\/1078-0432.CCR-11-1049","volume":"18","author":"Dietrich S.","year":"2012","unstructured":"Dietrich S.; Kr\u00e4mer O.H.; Hahn E.; Sch\u00e4fer C.; Giese T.; Hess M.; Tretter T.; Rieger M.; H\u00fcllein J.; Zenz T.; Ho A.D.; Dreger P.; Luft T.; Leflunomide induces apoptosis in fludarabine-resistant and clinically refractory CLL cells. Clin Cancer Res 2012,18(2),417-431","journal-title":"Clin Cancer Res"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1182\/blood-2014-06-580480","volume":"125","author":"Maude S.L.","year":"2015","unstructured":"Maude S.L.; Dolai S.; Delgado-Martin C.; Vincent T.; Robbins A.; Selvanathan A.; Ryan T.; Hall J.; Wood A.C.; Tasian S.K.; Hunger S.P.; Loh M.L.; Mullighan C.G.; Wood B.L.; Hermiston M.L.; Grupp S.A.; Lock R.B.; Teachey D.T.; Efficacy of JAK\/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia. Blood 2015,125(11),1759-1767","journal-title":"Blood"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1182\/blood-2002-05-1521","volume":"101","author":"Cull V.S.","year":"2003","unstructured":"Cull V.S.; Tilbrook P.A.; Bartlett E.J.; Brekalo N.L.; James C.M.; Type I interferon differential therapy for erythroleukemia: specificity of STAT activation. Blood 2003,101(7),2727-2735","journal-title":"Blood"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1182\/blood.V114.22.85.85","volume":"114","author":"Zhang J.","year":"2009","unstructured":"Zhang J.; Mullighan C.G.; Harvey R.C.; Buetow K.E.; Carroll W.L.; Chen I.M.; Devidas M.; Edmonson M.; Gerhard D.; Hu Y.; Loh M.L.; Phillips L.A.; Reaman G.H.; Relling M.V.; Smith M.; Downing J.R.; Willman C.L.; Hunger S.P.; Mutations in the RAS Signaling, B-Cell Development, TP53\/RB1, and JAK signaling pathways are common in high risk B-precursor childhood acute lymphoblastic leukemia (ALL): A Report From the Children\u2019s Oncology Group (COG) High-Risk (HR) ALL TARGET Project. Blood 2009,114(22),85-85","journal-title":"Blood"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1007\/s00018-015-1867-5","volume":"72","author":"Bertacchini J.","year":"2015","unstructured":"Bertacchini J.; Heidari N.; Mediani L.; Capitani S.; Shahjahani M.; Ahmadzadeh A.; Saki N.; Targeting PI3K\/AKT\/mTOR network for treatment of leukemia. Cell Mol Life Sci 2015,72(12),2337-2347","journal-title":"Cell Mol Life Sci"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"4256","DOI":"10.1200\/JCO.2003.99.170","volume":"21","author":"Abruzzese E.","year":"2003","unstructured":"Abruzzese E.; Cantonetti M.; Morino L.; Orlandi G.; Tendas A.; Del Principe M.I.; Masi M.; Amadori S.; Orlandi A.; Anemona L.; Campione E.; CNS and cutaneous involvement in patients with chronic myeloid leukemia treated with imatinib in hematologic complete remission: two case reports. J Clin Oncol 2003,21(22),4256-4258","journal-title":"J Clin Oncol"},{"key":"ref=52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088298","volume":"9","author":"Huang F.F.","year":"2014","unstructured":"Huang F.F.; Zhang L.; Wu D.S.; Yuan X.Y.; Yu Y.H.; Zhao X.L.; Chen F.P.; Zeng H.; PTEN regulates BCRP\/ABCG2 and the side population through the PI3K\/Akt pathway in chronic myeloid leukemia. PLoS One 2014,9(3)","journal-title":"PLoS One"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/onc.2013.587","volume":"34","author":"Pasmant E.","year":"2015","unstructured":"Pasmant E.; Gilbert-Dussardier B.; Petit A.; de Laval B.; Luscan A.; Gruber A.; Lapillonne H.; Deswarte C.; Goussard P.; Laurendeau I.; Uzan B.; Pflumio F.; Brizard F.; Vabres P.; Naguibvena I.; Fasola S.; Millot F.; Porteu F.; Vidaud D.; Landman-Parker J.; Ballerini P.; SPRED1, a RAS MAPK pathway inhibitor that causes Legius syndrome, is a tumour suppressor downregulated in paediatric acute myeloblastic leukaemia. Oncogene 2015,34(5),631-638","journal-title":"Oncogene"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s11684-013-0304-0","volume":"7","author":"Fredericks J.","year":"2013","unstructured":"Fredericks J.; Ren R.; The role of RAS effectors in BCR\/ABL induced chronic myelogenous leukemia. Front Med 2013,7(4),452-461","journal-title":"Front Med"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00277-008-0593-6","volume":"88","author":"Raepple D.","year":"2009","unstructured":"Raepple D.; von Lintig F.; Zemojtel T.; Duchniewicz M.; Jung A.; L\u00fcbbert M.; Boss G.R.; Scheele J.S.; Determination of Ras-GTP and Ras-GDP in patients with acute myelogenous leukemia (AML), myeloproliferative syndrome (MPS), juvenile myelomonocytic leukemia (JMML), acute lymphocytic leukemia (ALL), and malignant lymphoma: assessment of mutational and indirect activation. Ann Hematol 2009,88(4),319-324","journal-title":"Ann Hematol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s12013-014-0036-z","volume":"70","author":"Ramireddy L.","year":"2014","unstructured":"Ramireddy L.; Lin C.Y.; Liu S.C.; Lo W.Y.; Hu R.M.; Peng Y.C.; Peng C.T.; Association study between macrophage migration inhibitory factor-173 polymorphism and acute myeloid leukemia in Taiwan. Cell Biochem Biophys 2014,70(2),1159-1165","journal-title":"Cell Biochem Biophys"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2174\/156800912798888992","volume":"12","author":"Herrmann H.","year":"2012","unstructured":"Herrmann H.; Kneidinger M.; Cerny-Reiterer S.; R\u00fclicke T.; Willmann M.; Gleixner K.V.; Blatt K.; H\u00f6rmann G.; Peter B.; Samorapoompichit P.; Pickl W.; Bharate G.Y.; Mayerhofer M.; Sperr W.R.; Maeda H.; Valent P.; The Hsp32 inhibitors SMA-ZnPP and PEG-ZnPP exert major growth-inhibitory effects on D34+\/CD38+ and CD34+\/CD38- AML progenitor cells. Curr Cancer Drug Targets 2012,12(1),51-63","journal-title":"Curr Cancer Drug Targets"},{"key":"ref=58","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.58","volume":"5","author":"Kong Y.","year":"2015","unstructured":"Kong Y.; Zhang J.; Claxton D.F.; Ehmann W.C.; Rybka W.B.; Zhu L.; Zeng H.; Schell T.D.; Zheng H.; PD-1(hi)TIM-3(+) T cells associate with and predict leukemia relapse in AML patients post allogeneic stem cell transplantation. Blood Cancer J 2015,5","journal-title":"Blood Cancer J"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"26052","DOI":"10.18632\/oncotarget.4482","volume":"6","author":"Morton S.D.","year":"2015","unstructured":"Morton S.D.; Cadamuro M.; Brivio S.; Vismara M.; Stecca T.; Massani M.; Bassi N.; Furlanetto A.; Joplin R.E.; Floreani A.; Fabris L.; Strazzabosco M.; Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K\/AKT-dependent Mcl-1 activation. Oncotarget 2015,6(28),26052-26064","journal-title":"Oncotarget"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"10064","DOI":"10.1523\/JNEUROSCI.2981-04.2004","volume":"24","author":"Goldshmit Y.","year":"2004","unstructured":"Goldshmit Y.; Galea M.P.; Wise G.; Bartlett P.F.; Turnley A.M.; Axonal regeneration and lack of astrocytic gliosis in EphA4-deficient mice. J Neurosci 2004,24(45),10064-10073","journal-title":"J Neurosci"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1152\/japplphysiol.01399.2010","volume":"111","author":"Broholm C.","year":"2011","unstructured":"Broholm C.; Laye M.J.; Brandt C.; Vadalasetty R.; Pilegaard H.; Pedersen B.K.; Scheele C.; LIF is a contraction-induced myokine\n stimulating human myocyte proliferation. J Appl Physiol (1985) 2011,111(1),251-259","journal-title":"J Appl Physiol (1985)"},{"key":"ref=62","first-page":"61","author":"Dzhavadov S.S.","year":"2009","unstructured":"Dzhavadov S.S.; Sule\u012dmanova T.; [Collonization of intestinal tract of leukaemia patients with Candida and development of systemic candidemia]. Georgian Med News 2009(170),61-63","journal-title":"Georgian Med News"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.1093\/hmg\/dds302","volume":"21","author":"Stocco G.","year":"2012","unstructured":"Stocco G.; Yang W.; Crews K.R.; Thierfelder W.E.; Decorti G.; Londero M.; Franca R.; Rabusin M.; Valsecchi M.G.; Pei D.; Cheng C.; Paugh S.W.; Ramsey L.B.; Diouf B.; McCorkle J.R.; Jones T.S.; Pui C.H.; Relling M.V.; Evans W.E.; PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity. Hum Mol Genet 2012,21(21),4793-4804","journal-title":"Hum Mol Genet"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"99","DOI":"10.5045\/br.2013.48.2.99","volume":"48","author":"Lee J.M.","year":"2013","unstructured":"Lee J.M.; Kim J.E.; Bae S.H.; Hah J.O.; Efficacy of pamidronate in children with low bone mineral density during and after chemotherapy for acute lymphoblastic leukemia and non-Hodgkin lymphoma. Blood Res 2013,48(2),99-106","journal-title":"Blood Res"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/pbc.24313","volume":"60","author":"Leblicq C.","year":"2013","unstructured":"Leblicq C.; Laverdi\u00e8re C.; D\u00e9carie J.C.; Delisle J.F.; Isler M.H.; Moghrabi A.; Chabot G.; Alos N.; Effectiveness of pamidronate as treatment of symptomatic osteonecrosis occurring in children treated for acute lymphoblastic leukemia. Pediatr Blood Cancer 2013,60(5),741-747","journal-title":"Pediatr Blood Cancer"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/term.1628","volume":"9","author":"Limb J.K.","year":"2015","unstructured":"Limb J.K.; Song D.; Jeon M.; Han S.Y.; Han G.; Jhon G.J.; Bae Y.S.; Kim J.; 2-(trimethylammonium)ethyl (R)-3-methoxy-3-oxo-2-stearamidopropyl phosphate promotes megakaryocytic differentiation of myeloid leukaemia cells and primary human CD34 haematopoietic stem cells. J Tissue Eng Regen Med 2015,9(4),435-446","journal-title":"J Tissue Eng Regen Med"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.neurol.2015.07.002","volume":"171","author":"Sarrouilhe D.","year":"2015","unstructured":"Sarrouilhe D.; Dejean C.; [Gap junctions: A new therapeutic target in major depressive disorder?]. Rev Neurol (Paris) 2015,171(11),762-767","journal-title":"Rev Neurol (Paris)"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"31508","DOI":"10.18632\/oncotarget.5226","volume":"6","author":"Sinyuk M.","year":"2015","unstructured":"Sinyuk M.; Alvarado A.G.; Nesmiyanov P.; Shaw J.; Mulkearns-Hubert E.E.; Eurich J.T.; Hale J.S.; Bogdanova A.; Hitomi M.; Maciejewski J.; Huang A.Y.; Saunthararajah Y.; Lathia J.D.; Cx25 contributes to leukemia cell communication and chemosensitivity. Oncotarget 2015,6(31),31508-31521","journal-title":"Oncotarget"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1016\/s0024-3205(00)00885-7","volume":"67","author":"Guerra M.C.","year":"2000","unstructured":"Guerra M.C.; Speroni E.; Broccoli M.; Cangini M.; Pasini P.; Minghett A.; Crespi-Perellino N.; Mirasoli M.; Cantelli-Forti G.; Paolini M.; Comparison between chinese medical herb Pueraria lobata crude extract and its main isoflavone puerarin antioxidant properties and effects on rat liver CYP-catalysed drug metabolism. Life Sci 2000,67(24),2997-3006","journal-title":"Life Sci"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/tox.20717","volume":"28","author":"Wang H.","year":"2013","unstructured":"Wang H.; Xi S.; Liu Z.; Yang Y.; Zheng Q.; Wang F.; Xu Y.; Wang Y.; Zheng Y.; Sun G.; Arsenic methylation metabolism and liver injury of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment. Environ Toxicol 2013,28(5),267-275","journal-title":"Environ Toxicol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ejphar.2013.09.041","volume":"721","author":"Kostrzewa-Nowak D.","year":"2013","unstructured":"Kostrzewa-Nowak D.; Tarasiuk J.; Bioreductive activation of mitoxantrone by NADPH cytochrome P450 reductase does not change its apoptotic stimuli properties in regard to sensitive and multidrug resistant leukaemia HL60 cells. Eur J Pharmacol 2013,721(1-3),141-150","journal-title":"Eur J Pharmacol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1592\/phco.24.13.1232.38095","volume":"24","author":"Ramalingam S.","year":"2004","unstructured":"Ramalingam S.; Lagattuta T.F.; Egorin M.J.; Hayes M.J.; Ramanathan R.K.; Biliary excretion of imatinib mesylate and its metabolite CGP 74588 in humans. Pharmacotherapy 2004,24(9),1232-1235","journal-title":"Pharmacotherapy"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1586\/14737140.2016.1151356","volume":"16","author":"Stagno F.","year":"2016","unstructured":"Stagno F.; Stella S.; Spitaleri A.; Pennisi M.S.; Di Raimondo F.; Vigneri P.; Imatinib mesylate in chronic myeloid leukemia: frontline treatment and long-term outcomes. Expert Rev Anticancer Ther 2016,16(3),273-278","journal-title":"Expert Rev Anticancer Ther"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.leukres.2013.01.020","volume":"37","author":"Nousome D.","year":"2013","unstructured":"Nousome D.; Lupo P.J.; Okcu M.F.; Scheurer M.E.; Maternal and offspring xenobiotic metabolism haplotypes and the risk of childhood acute lymphoblastic leukemia. Leuk Res 2013,37(5),531-535","journal-title":"Leuk Res"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1684\/bdc.2011.1502","volume":"98","author":"Ouerhani S.","year":"2011","unstructured":"Ouerhani S.; Nefzi M.A.; Menif S.; Safra I.; Douzi K.; Fouzai C.; Ben Ghorbel G.; Ben Bahria I.; Ben Ammar Elgaaied A.; Abbes S.; Influence of genetic polymorphisms of xenobiotic metabolizing enzymes on the risk of developing leukemia in a Tunisian population. Bull Cancer 2011,98(12),95-106","journal-title":"Bull Cancer"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.3390\/ijerph9082788","volume":"9","author":"Kanagal-Shamanna R.","year":"2012","unstructured":"Kanagal-Shamanna R.; Zhao W.; Vadhan-Raj S.; Nguyen M.H.; Fernandez M.H.; Medeiros L.J.; Bueso-Ramos C.E.; Over-expression of CYP2E1 mRNA and protein: implications of xenobiotic induced damage in patients with de novo acute myeloid leukemia with inv(16)(p13.1q22); CBFbeta-MYH11. Int J Environ Res Public Health 2012,9(8),2788-2800","journal-title":"Int J Environ Res Public Health"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.leukres.2008.12.006","volume":"33","author":"da Silva Silveira V.","year":"2009","unstructured":"da Silva Silveira V.; Canalle R.; Scrideli C.A.; Queiroz R.G.; Bettiol H.; Valera E.T.; Tone L.G.; Polymorphisms of xenobiotic metabolizing enzymes and DNA repair genes and outcome in childhood acute lymphoblastic leukemia. Leuk Res 2009,33(7),898-901","journal-title":"Leuk Res"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/MOH.0000000000000123","volume":"22","author":"Stein E.M.","year":"2015","unstructured":"Stein E.M.; Tallman M.S.; Mixed lineage rearranged leukaemia: pathogenesis and targeting DOT1L. Curr Opin Hematol 2015,22(2),92-96","journal-title":"Curr Opin Hematol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.biotechadv.2014.08.007","volume":"32","author":"Guo J.","year":"2014","unstructured":"Guo J.; Cahill M.R.; McKenna S.L.; O\u2019Driscoll C.M.; Biomimetic nanoparticles for siRNA delivery in the treatment of leukaemia. Biotechnol Adv 2014,32(8),1396-1409","journal-title":"Biotechnol Adv"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/bjh.12231","volume":"161","author":"Etchin J.","year":"2013","unstructured":"Etchin J.; Sanda T.; Mansour M.R.; Kentsis A.; Montero J.; Le B.T.; Christie A.L.; McCauley D.; Rodig S.J.; Kauffman M.; Shacham S.; Stone R.; Letai A.; Kung A.L.; Thomas Look A.; KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia. Br J Haematol 2013,161(1),117-127","journal-title":"Br J Haematol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.ccr.2013.08.011","volume":"24","author":"Nagamachi A.","year":"2013","unstructured":"Nagamachi A.; Matsui H.; Asou H.; Ozaki Y.; Aki D.; Kanai A.; Takubo K.; Suda T.; Nakamura T.; Wolff L.; Honda H.; Inaba T.; Haploinsufficiency of SAMD9L, an endosome fusion facilitator, causes myeloid malignancies in mice mimicking human diseases with monosomy 7. Cancer Cell 2013,24(3),305-317","journal-title":"Cancer Cell"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/labinvest.2008.163","volume":"89","author":"Mao H.","year":"2009","unstructured":"Mao H.; Diehl A.M.; Li Y.X.; Sonic hedgehog ligand partners with caveolin-1 for intracellular transport. Lab Invest 2009,89(3),290-300","journal-title":"Lab Invest"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s11010-005-9074-6","volume":"285","author":"Hossain Z.","year":"2006","unstructured":"Hossain Z.; Kurihara H.; Hosokawa M.; Takahashi K.; Docosahexaenoic acid and eicosapentaenoic acid-enriched phosphatidylcholine liposomes enhance the permeability, transportation and uptake of phospholipids in Caco-2 cells. Mol Cell Biochem 2006,285(1-2),155-163","journal-title":"Mol Cell Biochem"},{"key":"ref=84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0106010","volume":"9","author":"Ogai K.","year":"2014","unstructured":"Ogai K.; Kuwana A.; Hisano S.; Nagashima M.; Koriyama Y.; Sugitani K.; Mawatari K.; Nakashima H.; Kato S.; Upregulation of leukemia inhibitory factor (LIF) during the early stage of optic nerve regeneration in zebrafish. PLoS One 2014,9(8)","journal-title":"PLoS One"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1371\/journal.pone.0106010","volume":"123","author":"Ogai K.","year":"2012","unstructured":"Ogai K.; Kuwana A.; Mawatari K.; Sugitani K.; Nakashima H.; Kato S.; Intrinsic upregulation of leukemia inhibitory factor (LIF) in the retina after optic nerve injury in adult zebrafish. J Neurochem 2012,123,106-106","journal-title":"J Neurochem"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.mehy.2012.09.008","volume":"79","author":"Sun Q.","year":"2012","unstructured":"Sun Q.; Gao G.; Xiong J.; Wu Q.; Liu H.; Leukemia inhibitory factor receptor alpha-chain: a potential method for acute promyeloid leukemia therapy. Med Hypotheses 2012,79(6),864-866","journal-title":"Med Hypotheses"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s12288-016-0643-5","volume":"32","author":"Yu L.","year":"2016","unstructured":"Yu L.; Hu T.; Zou T.; Shi Q.; Chen G.; Chronic myelocytic leukemia (CML) patient-derived dendritic cells transfected with autologous total RNA induces CML-specific cytotoxicity. Indian J Hematol Blood Transfus [1].2016,32(4),397-404","journal-title":"Indian J Hematol Blood Transfus"}],"container-title":["Combinatorial Chemistry &amp; High Throughput Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/168660","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T03:33:45Z","timestamp":1594956825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/168660\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,19]]},"references-count":87,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,5,19]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1386207322666181231151900","relation":{},"ISSN":["1386-2073"],"issn-type":[{"value":"1386-2073","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5,19]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-06-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}